Plasma and sputum erythromycin concentrations in chronic bronchitis
Thorax
|June 1, 1980
Summary
This study on erythromycin stearate in chronic bronchitis patients found adequate plasma drug levels for fighting respiratory pathogens. However, sputum concentrations were variable and sometimes low, suggesting potential challenges in achieving effective lung tissue drug levels.
Area of Science:
- Pharmacology
- Respiratory Medicine
- Infectious Diseases
Background:
- Chronic bronchitis is a significant respiratory illness often requiring antibiotic treatment.
- Erythromycin is a macrolide antibiotic used for respiratory tract infections.
- Optimizing antibiotic delivery to respiratory tissues is crucial for treatment efficacy.
Purpose of the Study:
- To evaluate plasma and sputum concentrations of a new erythromycin stearate formulation.
- To assess the gastrointestinal absorption and tissue penetration of erythromycin in chronic bronchitis patients.
- To compare drug concentrations with minimal inhibitory concentrations (MICs) for relevant pathogens.
Main Methods:
- 10 patients with chronic bronchitis received an eight-day course of erythromycin stearate.
- Plasma and sputum samples were collected to measure erythromycin concentrations.
- Drug levels were compared to MICs for common respiratory pathogens.
Main Results:
- Plasma erythromycin levels were favorable compared to MICs, indicating good absorption when taken before food.
- Sputum erythromycin levels were highly variable, often low or undetectable.
- Measurable sputum levels were ~10% of plasma levels, with no accumulation observed.
- Sputum concentrations were generally similar to MICs, except for Haemophilus influenzae.
- No correlation found between sputum and plasma levels; trends suggested higher sputum levels with increased pus and plasma concentrations.
Conclusions:
- The new erythromycin stearate formulation demonstrates adequate gastrointestinal absorption.
- Variable sputum penetration may limit efficacy against certain respiratory pathogens in chronic bronchitis.
- Further research is needed to optimize erythromycin delivery to lung tissues for chronic bronchitis treatment.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Sputum Studies II: Culture and Sensitivity
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...


